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1. Introduction 
Human lactotransferrin (also called lactoferrin) 
[l-3] consists of a single polypeptide chain of 
molecular weight 76 500 [4,5] and possesses two 
carbohydrate groups which are conjugated to the 
protein by an asparaginyl-N-acetylglucosamine linkage 
[6] : their structures were established by Spik et al. 
[7,8]. However, the present knowledge of the amino 
acid sequence of human lactotransferrin remains very 
limited: some cyanogen bromide fragments have .been 
purified and analyzed [9] and six short cysteic acid 
containing peptides [lo] as well as short tryptic and 
chymotryptic glycopeptides [7,8,1 l] have been 
sequenced. Finally glycine has been identified as the 
N-terminal amino acid [IO] . 
The present paper is dealing with the establish- 
ment of the N-terminal sequence of human lacto- 
transferrin and of the corresponding cyanogen bromide 
fragment. Extensive similarities were thus demon- 
strated between the N-terminal regions of the ovo-, 
serum- and lactotransferrins. 
2. Materials and methods 
Human lactotransferrin was obtained according to 
Cheron et al. [12] . The protein was reduced following 
the procedure of Crestfield et al. [13] ; iodoacetamide 
was employed for the alkylation step. The preparation 
and purification of the cyanogen bromide (CNBr) 
fragments were reported by Mazurier et al. [9 and 
unpublished results] . 
The N-terminal amino acids of the protein and of 
North-Holland Publishing Company -Amsterdam 
the CNBr-fragment were identified by the dansylation 
procedure. Automated Edman degradation was carried 
out in a Socosi Sequencer Model PS-100, by the 
quadrol double-cleavage method [ 141; dithioeri- 
thrytol was added in I-chlorobutane (10 mg/l). The 
thiazolinones were converted into the corresponding 
phenylthiohydantoin (PTH)-amino acids; the latter 
were characterized, as previously reported [ 151, by 
thin-layer chromatography, by gas-liquid chromato- 
graphy (Beckman GC 45 chromatograph) and by 
chromatography of the free amino acids (Technicon 
amino acid Autoanalyzer) regenerated from the PTH- 
amino acids (150°C; 24 h; 6 M HCl containing 
l/2000 2-mercaptoethanol). 
The chymotryptic digestion of CNBr-fragment 
F-V’ was performed during 24 h at 37’C in 0.05 M 
NH4HC03 with an eniymelsubstrate ratio of l/20. 
The chymotryptic peptides were purified by paper 
electrophoresis (Whatman No. 1) at pH 6.5 (pyridine- 
water-acetic acid, 100 : 900 : 4, v/v/v) and 50 V/cm. 
3. Results 
3.1. N-terminal sequence of human lactotransfem’n 
By the dansylation procedure, Gly was charac- 
terized as the N-terminal amino acid of the protein. 
By automated Edman degradation, the ten first 
amino acids could be identified (table 1). 
3.2. i%e N-terminal cyanogen bromide fragment of 
human lactotransferrin: characterization of the 
first 24 amino acids of the protein 
7 CNBr-fragments (F-I to F-VII) have so far been 
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Table 1 
October 1976 
N-terminal sequences of human lactotransferrin and of the cyanogen bromide fragment F-V’ (N-terminal 
moiety of the intact lactotransferrin molecule). Methods of identification were as follows: (a) +, 
PTH-derivative determined by thin-layer chromatography; cysteine was determined as PTH-S-carbox- 
amidomethylcysteine; (b) PTH-amino acid determined by gas-liquid chromatography, yield %; (c) amino 


































Ser Ser (11) 
Val Val (12) 
Gln 































































































* Characterized by thin-layer chromatography during 3.5 h (instead of 0.5 h) in solvent 7 (15) and staining 
with the Sakaguchi reagent. 
Table 2 
Mobility m (at pH 6.5) values, yields and structures of the chymotryptic peptides of fragment F-V’ of human 
lactotransferrin. m = 0 for Gly; m = +l for Arg; m = -1 for CySO,H. 
Peptide m 
C-l + 1.15 35 
c-2 0 35 
c-3 -0.25 50 
C-4 -0.56 15 
c-5 + 0.58 32 








Gln-(Asx, Ser, Ala, Val, Arg,)-HSer* 
Gln-Trp-Gln-(Asx, Ser, Ala, Val, Arg,)-HSer* 
* PyrGlu, pyrrolidonecarboxylic acid; HSer, homoserine. 
** C-6 = C-4 + C-5. 
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isolated [9]. During further purification of fragment 
F-V, a peptide F-V’ was obtained by filtration on 
Biogel P6 with 10% acetic acid as eluent followed by 
chromatography on Dowex 1 X 2 with a pyridine 
(IO%)-acetic acid buffer of pH 8.4. 
Its amino acid composition was established 
(residues/mole b tween parentheses): Asp (1) Thr (l), 
Ser (3), Glu (5), Pro (1) Gly (1) Ala (3) CYS (2), 
W(3), Phe (1) Trp (2) Lys (11, &I (6X H.&r (1). 
F-V’ was submitted to automated Edman degradation. 
Table 1 indicates that this fragment constitutes the 
N-terminal region of human lactotransferrin; a sequence 
constituted by the first 24 amino acids was established, 
and this result is reported for the tirst time. 
Fragment F-V’ was further submitted to a chymo- 
tryptic digestion. Table 2 indicates the mobilities, 
yields and structures of six chymotryptic peptides 
(C-l to C-6) in the order as they appear in the sequence 
Peptide C-6 was composed of peptides C-4 + C-5; in 
C-4, glutamine was characterized as pyrrolidone- 
carboxylic acid. An unusual chymotryptic split was 
observed after the fourth arginine residue of F-V’. 
The study of peptides C-l to C-6 corroborated the 
data established by automated Edman degradation. 
4. Discussion 
4.1. Comparison of the amino terminal regions of 
3 transferrins 
From the N-terminal sequence of human serum 
transferrin which we previously published [161 and 
present data concerning human lactotransferrin, the 
alignments proposed in table 3 could be constructed; 
they demonstrate strikingly the extensive similarity 
between the N-terminal regions of the two proteins. 
We point out more particularly the satisfactory 
alignment of the cysteinyl residues present in both 
sequences: this was not possible when the N-terminal 
sequence of serum transferrin proposed by Sutton 
and Brew [ 171 was considered. Our results were in 
accordance with the highly conservative behaviour of 
cysteinyl residues during evolution, a fact illustrated 
by several other published phylogenetic protein data. 
Table 3 also includes William’s recently established 
long N-terminal sequence of hen ovotransferrin 
30 
quoted, without details, by Bluard-Deconinck etal. 
[ 181 despite the fact that it differs from previously 
published ata by Elleman and Williams [191; indeed 
the N-terminal sequence of hen transferrin presents 
again a close homology with the corresponding 
sequences of the two human transferrins. 
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